Anshan Hifichem Co., Ltd.

SZSE:300758.SZ

9.66 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 411.864322.546328.494317.704308.047263.578278.869296.526309.968323.191413.263323.368301.08309.186314.119268.805249.426175.953182.691165.487199.584146.823149.151168.066164.358129.375148.952144.546131.83131.83117.072117.072103.918103.91894.02394.02390.73790.737
Cost of Revenue 289.345225.347229.808228.528234.556206.766213.551219.916239.097219.714290.652221.894202.074206.486212.463175.41155.673107.219109.26797.664121.033105.639102.459106.488105.21382.59293.0790.48684.56284.56214.08614.086157.931157.93165.88365.88360.29160.291
Gross Profit 122.51997.19998.68589.17673.49156.81265.31776.6170.871103.476122.61101.47499.006102.7101.65693.39593.75368.73473.42567.82378.55141.18446.69161.57859.14546.78355.88354.0647.26847.268102.986102.986-54.014-54.01428.1428.1430.44630.446
Gross Profit Ratio 0.2970.3010.30.2810.2390.2160.2340.2580.2290.320.2970.3140.3290.3320.3240.3470.3760.3910.4020.410.3940.280.3130.3660.360.3620.3750.3740.3590.3590.880.88-0.52-0.520.2990.2990.3360.336
Reseach & Development Expenses 22.46116.94622.84819.08118.26921.0520.35526.08823.27621.25427.32819.78519.82114.79918.6912.33211.888.32512.875.2135.5367.4899.0624.7625.1645.8035.8415.8414.8754.87500000000
General & Administrative Expenses -5.40532.416-58.49477.578-14.64934.736-21.94166.4034.57828.598-21.42745.068-4.19813.964-17.11616.123-0.6239.345-11.8767.4415.0515.816-23.7945.807-8.3685.782-56.1454.9194.3324.33299.61599.61581.17681.17610.8610.867.3547.354
Selling & Marketing Expenses 10.1837.57513.20110.8910.64110.42114.74712.14310.11310.91215.86213.0938.33613.2533.70510.8739.6817.91111.9198.349.3497.3548.1988.6748.1318.0177.3716.0856.9796.9795.6185.6184.5594.5594.8524.8524.5134.513
SG&A 32.23939.991-45.29388.468-4.00745.157-7.19478.54614.69139.51-5.56558.1614.13827.217-13.41126.9969.05817.2560.04315.78114.413.17-15.59614.48-0.23713.799-48.7759.72611.31111.311105.233105.23376.61776.61715.71215.71211.86711.867
Other Expenses -11.171-0.095-2.432-0.8590.519-0.36-0.2650.504-1.586-1.79711.166-17.63527.4554.85-2.097-0.8216.885-1.164-31.984-0.167-0.511-0.027-0.362-0.883.257-0.0446.99600000000000
Operating Expenses 65.87157.62469.94266.3660.67868.42878.55777.58168.11963.15876.47457.77247.41844.31840.46738.29536.02726.16435.86422.79231.6222.03325.25721.17121.17221.13720.02618.21320.69520.695101.681101.68168.28868.28817.54517.54518.43418.434
Operating Income 56.64825.44114.5959.9564.038-17.331-32.963-3.5484.27933.00337.51143.91270.83256.11756.6951.43356.3643.48438.55449.04350.08116.99521.62939.29937.4122.29635.84435.86829.77129.77123.69523.69521.74921.74911.64611.64617.84917.849
Operating Income Ratio 0.1380.0790.0440.0310.013-0.066-0.118-0.0120.0140.1020.0910.1360.2350.1810.180.1910.2260.2470.2110.2960.2510.1160.1450.2340.2280.1720.2410.2480.2260.2260.2020.2020.2090.2090.1240.1240.1970.197
Total Other Income Expenses Net -4.886-0.095-2.432-0.243-0.097-0.36-1.431-0.755-0.328-1.797-2.119-1.4711.2894.85-1.69-0.8216.885-1.164-31.569-0.167-0.511-0.027-0.362-0.88-0.016-0.044-1.073-1.798-2.929-2.9296.0366.036-7.475-7.475-1.05-1.05-5.837-5.837
Income Before Tax 51.76225.34612.1649.7143.941-17.691-34.394-4.3023.95131.20535.39242.44282.12160.9675550.61263.24642.326.98648.87649.56916.96821.26838.41937.39422.25134.77134.0726.84226.84229.73229.73214.27514.27510.59610.59612.01212.012
Income Before Tax Ratio 0.1260.0790.0370.0310.013-0.067-0.123-0.0150.0130.0970.0860.1310.2730.1970.1750.1880.2540.2410.0380.2950.2480.1160.1430.2290.2280.1720.2330.2360.2040.2040.2540.2540.1370.1370.1130.1130.1320.132
Income Tax Expense 4.7463.004-1.986-0.623-1.044-5.307-11.5-4.463-1.1162.2270.6913.59.656.8386.7165.7517.8165.376-0.8026.6016.8541.6471.8225.0525.2991.7836.2695.2943.9253.9254.6924.6921.4791.4791.5451.5451.6491.649
Net Income 45.60621.59514.8817.9642.962-14.805-25.858-2.5941.02824.6530.04536.92964.88248.11542.17641.57954.75736.9457.78842.27542.71515.32119.44633.36732.09520.46928.50228.77522.91722.91725.03925.03912.79612.7969.059.0510.36310.363
Net Income Ratio 0.1110.0670.0450.0250.01-0.056-0.093-0.0090.0030.0760.0730.1140.2150.1560.1340.1550.220.210.0430.2550.2140.1040.130.1990.1950.1580.1910.1990.1740.1740.2140.2140.1230.1230.0960.0960.1140.114
EPS 0.110.050.0370.020.007-0.037-0.064-0.0060.0030.0610.0740.0920.180.150.130.130.170.110.0240.240.160.0560.0810.140.130.0850.120.120.160.160.180.180.0890.0890.0640.0640.0720.072
EPS Diluted 0.110.050.0370.020.007-0.037-0.064-0.0060.0030.060.0740.0920.180.150.130.130.170.110.0240.240.160.0560.0810.140.130.0850.120.120.160.160.180.180.0890.0890.0640.0640.0720.072
EBITDA 97.341.61524.89421.75622.755-11.244-10.8517.8227.45238.87457.62728.9180.02564.23658.06753.63766.48344.7347.62649.49450.93619.29329.31948.36542.41524.76948.64742.87137.30537.30531.68131.68129.43329.43320.38120.38126.38426.384
EBITDA Ratio 0.2360.1290.0760.0680.074-0.043-0.0390.0260.0240.120.1390.0890.2660.2080.1850.20.2670.2540.0420.2990.2550.1310.1970.2880.2580.1910.3270.2970.2830.2830.2710.2710.2830.2830.2170.2170.2910.291